Back
Vistagen Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
VTGN
Vistagen Therapeutics
Last Price:
$2.34
Seasonality Move:
-9.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and VTGN is experiencing slight buying pressure.
Vistagen Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.2 | Buy |
| 20-day SMA: | 2.19 | Buy |
| 50-day SMA: | 2.52 | Sell |
| 200-day SMA: | 2.93 | Sell |
| 8-day EMA: | 2.23 | Buy |
| 20-day EMA: | 2.27 | Buy |
| 50-day EMA: | 2.45 | Sell |
| 200-day EMA: | 2.99 | Sell |
Vistagen Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 48.83 | Sell |
| Chaikin Money Flow: | 4353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.49) | Buy |
| Bollinger Bands (100): | (2.35 - 2.95) | Sell |
Vistagen Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vistagen Therapeutics Stock
Is Vistagen Therapeutics Stock a Buy?
-
Vistagen Therapeutics share price is 2.29 while VTGN 8-day simple moving average is 2.20, which is a Buy signal.
-
The stock price of VTGN is 2.29 while Vistagen Therapeutics 20-day SMA is 2.19, which makes it a Buy.
-
Vistagen Therapeutics 50-day simple moving average is 2.52 while VTGN share price is 2.29, making it a Sell technically.
-
VTGN stock price is 2.29 and Vistagen Therapeutics 200-day simple moving average is 2.93, creating a Sell signal.
VTGN Technical Analysis vs Fundamental Analysis
Sell
21
Vistagen Therapeutics (VTGN)
is a Sell
Is Vistagen Therapeutics a Buy or a Sell?
-
Vistagen Therapeutics stock is rated a SellThe current Vistagen Therapeutics [VTGN] share price is $2.29. The Score for VTGN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Vistagen Therapeutics Stock Info
Market Cap:
66.1M
Price in USD:
2.29
Share Volume:
41.5K
Vistagen Therapeutics 52-Week Range
52-Week High:
4.96
52-Week Low:
1.90
Sell
21
Vistagen Therapeutics (VTGN)
is a Sell
Vistagen Therapeutics Share Price Forecast
-
What is the Vistagen Therapeutics stock price today?The Vistagen Therapeutics stock price is 2.29 USD today.
-
Will VTGN stock go up or go down?Vistagen Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Vistagen Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vistagen Therapeutics is overvalued.
Is Vistagen Therapeutics Stock a Buy?
-
Vistagen Therapeutics share price is 2.29 while VTGN 8-day exponential moving average is 2.23, which is a Buy signal.
-
The stock price of VTGN is 2.29 while Vistagen Therapeutics 20-day EMA is 2.27, which makes it a Buy.
-
Vistagen Therapeutics 50-day exponential moving average is 2.45 while VTGN share price is 2.29, making it a Sell technically.
-
VTGN stock price is 2.29 and Vistagen Therapeutics 200-day simple moving average is 2.99, creating a Sell signal.
Fundamental Analysis of Vistagen Therapeutics
Is Vistagen Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.40 per share.
Technical Analysis of Vistagen Therapeutics
Should I short Vistagen Therapeutics stock?
-
VTGN Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Vistagen Therapeutics is a Sell
-
Vistagen Therapeutics Relative Strength Index (RSI) is 48.83, which suggest Vistagen Therapeutics is oversold
-
The Bollinger Bands (25) for Vistagen Therapeutics is (2.07 - 2.49), which suggest Vistagen Therapeutics is a Sell
-
The Bollinger Bands (100) for Vistagen Therapeutics is (2.35 - 2.95), which suggest Vistagen Therapeutics is a Sell
* Vistagen Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.